Prevalence of Molecular Breast Cancer Subtypes in Ethiopia: A Review

Abstract

Breast cancer is a heterogeneous diseases and it is difficult to provide the right treatment. Molecular markers are good indicators for prognosis and predictive factor. Therefore, the current review was designed to assess the prevalence of Molecular subtypes of Breast cancer in Ethiopia. The review concentrated on current literature on Prevalence, Breast Cancer, Women, Molecular Subtypes, Hormone Receptors and Ethiopia with scientifically proven efficacy was carried out using electronic databases such as Science Direct, Google Scholar and PubMed. Among a total of 4000 studies, six studies were included in this review. The current review showed that the prevalence of ER+, PR+ and Luminal A Breast cancer is high in Ethiopia. For this reason Ethiopian breast cancer patients will be take hormonal therapy. However, further study should be done on the prevalence of molecular subtypes of breast cancer via PCR and other laboratory method for clearly identification of the molecular markers.